Nervous System Diseases

1,005 trials 421 recruiting

Filter these 1,005 trials by phase, country and sponsor.

Open in Search →

Stopping or continuing blood thinners after stroke at young age without a known cause: STOP trial Recruiting

2024-513092-40-00 Stroke 6 2024-12-05
This 52-week, open-label extension study is to evaluate the long-term safety and tolerability of ACP-204 in subjects with ADP. Recruiting

2023-507351-29-00 Alzheimer's Disease Psychosis 5 2024-12-03
Evaluation of the Safety and Efficacy of Metformin in Steinert's Disease: A Prospective, Multicenter, Randomized, Double Blind, Phase 3 Tria… Recruiting

2023-507660-39-00 Myotonic dystrophy type 1 (DM1) 5 2024-12-03
Tau PET imaging in cognitively normal elderly subjects: A twin approach Recruiting

2024-517634-17-01 Healthy controls (investigating preclinical Alzheimer's 4 2024-12-02
Randomized, double-blind, placebo-controlled trial of the efficacy and safety of tianeptine in the treatment of covid fog symptoms in patien… Recruiting

2024-510790-19-00 Covid fog - a dysfunctional condition characterized by 4 2024-12-02
A clinical study to assess the efficacy and safety of leriglitazone in adult male subjects with cerebral adrenoleukodystrophy. Recruiting

2024-515104-39-00 Cerebral adrenoleukodystrophy (cALD) 5 2024-12-02
Evaluation of the addition of Everolimus to 177Lu-DOTATATE in the treatment of grades 2 and 3 refractory meningioma: a phase IIb clinical tr… Recruiting

2023-508400-38-00 meningioma 4 2024-11-29
Amyloid pathology in cognitively normal elderly subjects (PreclinAD) Recruiting

2024-518559-41-01 Healthy controls (investigating preclinical Alzheimer's 4 2024-11-29
Use of statins in patients with intracerebral hemorrhage Recruiting

2024-511465-11-00 Spontaneous lobar ICH 5 2024-11-20
Phase 1 study to evaluate [18F]ACI-19626 as a potential PET radioligand for imaging TDP-43 inclusions in the brain of patients with suspecte… Recruiting

2024-513097-21-00 Alzheimer's Disease 1 2024-11-20
Multicentre Randomized trial of Ghrelin in anterior circulation ischemic stroke treated with endovascular thrombectomy. A randomized phase 2… Recruiting

2024-515705-26-00 Stroke 4 2024-11-11
Hypertension induced by intravenous administration of norepinephrine to improve the prognosis of patients with neurological deterioration in… Recruiting

2023-508704-37-00 Stroke 5 2024-11-08
New adjuvant vaccine in glioblastoma, a Phase 1/2a study (NAVIG-1) Recruiting

2024-514567-26-00 glioblastoma 7 2024-11-08
An Off-Label Single Arm Clinical Study to Evaluate the Efficacy and Safety of doxecitine and doxribtimine in Adult Subjects with Thymidine K… Recruiting

2024-510763-35-00 Organic compound 4 2024-11-05
Multicenter randomized, double-blind, placebo controlled trial evaluating the effect of a 30-week caffeine treatment on cognition in early-t… Recruiting

2024-514099-41-00 Alzheimer's disease 5 2024-10-31
No Evidence Of Disease Activity After Autologous Haematopoietic Stem Cell Transplantation In Aggressive Multiple Sclerosis Recruiting

2024-515470-26-00 Relapsing Remitting Multiple Sclerosis 4 2024-10-31
Anakinra in Cerebral haemorrhage to Target secondary Injury resulting from Neuroinflammation - a phase II clinical trial Recruiting

2024-517230-17-00 Intracerebral haemorrhage 4 2024-10-28
Cell therapy for Inclusion Body Myositis (IBM) by muscle injection of autologous uncultured Adipose-Derived Stromal Vascular Fraction (ADSVF… Recruiting

2024-511858-44-00 Inclusion Body Myositis 7 2024-10-24
BevacizuMAV : Evaluation of the efficacy and safety of anti-angiogenic treatment with intravenous bevacizumab in patients with symptomatic c… Recruiting

2023-508464-30-00 cerebral arteriovenous malformations 4 2024-10-24
Oxidative Phosphorylation Targeting In Malignant glioma Using Metformin plus radiotherapy temozolomide Recruiting

2024-511026-31-01 Glioblastoma grade 4 4 2024-10-24
An interventional, multi-center, randomized, double blinded, placebo controlled study to investigate semaglutide add-on treatment for metabo… Recruiting

2023-506109-20-00 Metabolic control in antipsychotic-using patients 5 2024-10-19
PRO-HEB.Efficacy of Propranolol for the treatment of central nervous system hemangioblastomas in von Hippel-Lindau disease: a randomized con… Recruiting

2024-516241-39-00 Von Hippel-Lindau (VHL) disease 5 2024-10-16
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Recruiting

2023-508539-30-00 Refractory Focal Onset Epilepsy 4 2024-10-10
TAP-TAU Recruiting

2023-505430-10-00 Mild cognitive impairment and dementia 10 2024-10-10